ONC insider buying and SEC filings, explained
BeiGene, Ltd. · CIK 1651308
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$15.6M
Planned sales (10b5-1)
$374.9M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 27, 2026 | Planned (10b5-1) | Xiaodong Wang (Director and Chair, Scientific Advisory Brd) sold 31,028 shares at about $362.97 ($11.3M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 29, 2026, 5:04 PM ET |
| Oct 13, 2026 | Planned (10b5-1) | Xiaodong Wang (Director and Chair, Scientific Advisory Brd) sold 31,027 shares at about $350.99 ($10.9M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 15, 2026, 5:08 PM ET |
| Sep 30, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 1,115 shares at $375.00 ($418K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 2, 2026, 4:53 PM ET |
| Sep 28, 2026 | Planned (10b5-1) | Xiaodong Wang (Director and Chair, Scientific Advisory Brd) sold 31,028 shares at about $364.79 ($11.3M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 30, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Xiaodong Wang (Director and Chair, Scientific Advisory Brd) sold 38,287 shares at about $349.10 ($13.4M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 10, 2026 |
| Sep 1, 2026 | Sale | Titus B. Ball (Principal Accounting Officer) sold 132 shares at $355.86 ($47K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Aug 25, 2026 | Planned (10b5-1) | Xiaobin Wu (President / COO) sold 280 shares at $380.00 ($106K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 27, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 2,666 shares at $360.00 ($960K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 13, 2026 |
| Aug 10–12, 2026 | Planned (10b5-1) | John Oyler (CEO and Director) sold 240,810 shares between Aug 10 and Aug 12 at about $359.12 ($86.5M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 12, 2026 |
| Aug 3, 2026 | Sale | Aaron Rosenberg (CFO) sold 1,157 shares at $312.72 ($362K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Jul 30, 2026 | Sale | Chan Henry Lee (SVP, General Counsel) sold 1,044 shares at $323.69 ($338K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 3, 2026 |
| Jul 22, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 1,669 shares at $325.00 ($542K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 24, 2026 |
| Jul 20–21, 2026 | Planned (10b5-1) | John Oyler (CEO and Director) sold 109,713 shares between Jul 20 and Jul 21 at about $315.29 ($34.6M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 22, 2026 |
| Jul 17, 2026 | Planned (10b5-1) | John Oyler (CEO and Director) sold 64,628 shares at about $312.00 ($20.2M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 15–16, 2026 | Planned (10b5-1) | John Oyler (CEO and Director) sold 283,154 shares between Jul 15 and Jul 16 at about $315.56 ($89.4M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 14, 2026 | Planned (10b5-1) | John Oyler (CEO and Director) sold 145,861 shares at about $305.95 ($44.6M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 10–13, 2026 | Planned (10b5-1) | John Oyler (CEO and Director) sold 60,218 shares between Jul 10 and Jul 13 at about $303.18 ($18.3M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 8, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 664 shares at $302.46 ($201K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 10, 2026 |
| Jun 23, 2026 | Sale | Lai Wang (President / COO) sold 1,068 shares at $276.74 ($296K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 25, 2026 |
| Jun 23, 2026 | Sale | Xiaobin Wu (President / COO) sold 1,292 shares at about $276.26 ($357K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 25, 2026 |
| Jun 23, 2026 | Sale | John Oyler (CEO and Director) sold 3,410 shares at about $273.78 ($934K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 25, 2026 |
| Jun 16, 2026 | Sale | Chan Henry Lee (SVP, General Counsel) sold 590 shares at $265.98 ($157K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 16, 2026 | Sale | Lai Wang (President / COO) sold 1,169 shares at about $265.39 ($310K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 16, 2026 | Sale | Xiaobin Wu (President / COO) sold 1,357 shares at about $266.76 ($362K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 16, 2026 | Sale | John Oyler (CEO and Director) sold 3,693 shares at about $265.55 ($981K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 11, 2026 | Sale | Aaron Rosenberg (CFO) sold 631 shares at about $257.74 ($163K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Sale | Chan Henry Lee (SVP, General Counsel) sold 428 shares at $257.64 ($110K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Sale | Lai Wang (President / COO) sold 756 shares at about $261.00 ($197K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Sale | Xiaobin Wu (President / COO) sold 626 shares at about $261.20 ($164K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Sale | Titus B. Ball (Principal Accounting Officer) sold 169 shares at about $257.20 ($43K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Sale | John Oyler (CEO and Director) sold 1,949 shares at about $257.24 ($501K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 8, 2026 | Sale | Chan Henry Lee (SVP, General Counsel) sold 871 shares at about $270.43 ($236K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 8, 2026 | Sale | Lai Wang (President / COO) sold 1,367 shares at about $269.38 ($368K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 8, 2026 | Sale | Xiaobin Wu (President / COO) sold 1,484 shares at about $269.36 ($400K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 8, 2026 | Sale | Titus B. Ball (Principal Accounting Officer) sold 136 shares at about $271.33 ($37K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 8, 2026 | Sale | John Oyler (CEO and Director) sold 4,940 shares at about $270.55 ($1.3M). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 1, 2026 | Sale | Qingqing Yi (Director) sold 235 shares at $279.13 ($66K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 22, 2026 | Sale | Margaret Dugan (Director) sold 212 shares at $309.60 ($66K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 22, 2026 | Sale | Alessandro Riva (Director) sold 212 shares at $309.51 ($66K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 22, 2026 | Sale | Corazon (Corsee) D. Sanders (Director) sold 212 shares at $309.59 ($66K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 22, 2026 | Sale | Julian Baker (Director) sold 10,998 shares indirectly at about $23.82 ($262K). Indirect holdings down 7% to 142,570 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed May 27, 2026 |
| May 13, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 332 shares at $310.72 ($103K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed May 15, 2026 |
| Apr 8, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 332 shares at $311.59 ($103K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Apr 10, 2026 |
| Mar 11, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 341 shares at $300.00 ($102K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Mar 13, 2026 |
| Feb 4, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 1,660 shares at about $349.52 ($580K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 6, 2026 |
| Jan 7, 2026 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 664 shares at $331.76 ($220K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 9, 2026 |
| Dec 15–16, 2025 | Planned (10b5-1) | John Oyler (CEO and Director) sold 100,000 shares between Dec 15, 2025 and Dec 16, 2025 at about $306.59 ($30.7M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 10–11, 2025 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 664 shares between Dec 10, 2025 and Dec 11, 2025 at about $321.64 ($214K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 12, 2025 |
| Nov 17, 2025 | Sale | Xiaobin Wu (President / COO) sold 3,991 shares at about $380.43 ($1.5M). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
| Nov 12, 2025 | Planned (10b5-1) | Chan Henry Lee (SVP, General Counsel) sold 996 shares at about $349.17 ($348K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 14, 2025 |
| Nov 12–13, 2025 | Sale | Xiaobin Wu (President / COO) sold 16,009 shares between Nov 12, 2025 and Nov 13, 2025 at about $365.22 ($5.8M). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 14, 2025 |
45 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ONC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.